SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Immunomedics (IMMU) - moderated
An SI Board Since September 2006
Posts SubjectMarks Bans Symbol
63365 356 15 IMMU
Emcee:  idahoranch1 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
63036Sarepta down 18% in pre-market. Rumor is patient death from a dear doctor letteraudioWCAG2.113/18/2025
63035Biolata EpCAM is overexpressed in a wide range of tumors, making it an ideaforgetme-3/16/2025
63034Biolata EpCAM is overexpressed in a wide range of tumors, making it an ideaforgetme-3/16/2025
63033biolata Tce program will have data at asco. Co has disclosed mtd has not been reforgetme-3/16/2025
63032No one here paying attention? investors.meiragtx.comaudioWCAG2.1-3/13/2025
63031Bluebird. finance.yahoo.comsysiphus-3/13/2025
63030ir.bioatla.com stock collapsed because partnership did not materializeforgetme-3/10/2025
63029abby400 different target and toxin with different linker ascopubs.org meetings.aforgetme-3/8/2025
63028ctmx currently at dose 7th active dose started at level 3 according to ceo fromforgetme13/7/2025
63027For holders of AUPH see news below: finance.yahoo.complhky346513/7/2025
63026Good to see this board still going strong. Top two biotech positions right nowaudioWCAG2.113/7/2025
63025AADI gurufocus.comsysiphus23/6/2025
63024just an update on SRPT: While the market is weak in general, and XBI has goneluckydog8813/4/2025
63023re: Joining the SAVA lawsuit. Daddy: I have the exact same reaction to these aerickerickson32/28/2025
63022re: SRPT target prices: <insert rant I've made ad-nauseam about financiaerickerickson-2/28/2025
63021Management guided revenues of about 3 billion for 2025. Market cap is only 10 bstockdoc7742/27/2025
63020For those SRPT followers: Earning were released last night, seemed largely withluckydog8812/27/2025
63019Am out. Can’t wait till 2027. Taking the hit and moving on.dorightbythem-2/25/2025
63018Apologies for popping in to just ask for random advice, but, a friend asked if Idiaperdaddy-2/25/2025
63017Anyone have any thought on VERA? TIACFL Invest 1-2/25/2025
63016BLUE: $3 in cash and potentially $6.84 in time. Another biotech investment doDavidoff32/21/2025
63015oqory.com ceo explained the reason for merger with vinc. This is a high risk stoforgetme-2/15/2025
63014vinc buy it after merger with quory? just had reverse split and will go out of bforgetme-2/15/2025
63013Over the last five years quarterly revenues have risen from 100 million to 700 mstockdoc7722/13/2025
63012For those following SRPT: Not sure why, but saw this come across Fidelity news luckydog88-2/13/2025
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News